ImmunityBio announced a strategic partnership with Accord Healthcare to distribute its drug Anktiva across 30 countries, backed by the establishment of a new subsidiary in Dublin to support European commercialisation. Despite these expansion efforts, shares fell at the open, even as retail sentiment remained firmly in the 'bullish' territory.